253 related articles for article (PubMed ID: 29341423)
1. Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome.
Crowley B; Ruffner M; McDonald McGinn DM; Sullivan KE
Am J Med Genet A; 2018 Oct; 176(10):2082-2086. PubMed ID: 29341423
[TBL] [Abstract][Full Text] [Related]
2. The immune deficiency of chromosome 22q11.2 deletion syndrome.
Morsheimer M; Brown Whitehorn TF; Heimall J; Sullivan KE
Am J Med Genet A; 2017 Sep; 173(9):2366-2372. PubMed ID: 28627729
[TBL] [Abstract][Full Text] [Related]
3. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes.
Sullivan KE; Jawad AF; Randall P; Driscoll DA; Emanuel BS; McDonald-McGinn DM; Zackai EH
Clin Immunol Immunopathol; 1998 Feb; 86(2):141-6. PubMed ID: 9473376
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Severity of T Cell Lymphopenia and Immune Dysregulation in Patients with DiGeorge Syndrome (22q11.2 Deletions and/or Related TBX1 Mutations): a USIDNET Study.
Deshpande DR; Demirdag YY; Marsh RA; Sullivan KE; Orange JS;
J Clin Immunol; 2021 Jan; 41(1):29-37. PubMed ID: 32949294
[TBL] [Abstract][Full Text] [Related]
5. Immune status of the murine 22q11.2 deletion syndrome model.
Crockett AM; Kebir H; Benallegue N; Adelman P; Gur RE; Sullivan K; Anderson SA; Alvarez JI
Eur J Immunol; 2023 Jan; 53(1):e2249840. PubMed ID: 36337041
[TBL] [Abstract][Full Text] [Related]
6. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
Perez EE; Bokszczanin A; McDonald-McGinn D; Zackai EH; Sullivan KE
Pediatrics; 2003 Oct; 112(4):e325. PubMed ID: 14523220
[TBL] [Abstract][Full Text] [Related]
7. Immunological aspects of 22q11.2 deletion syndrome.
Gennery AR
Cell Mol Life Sci; 2012 Jan; 69(1):17-27. PubMed ID: 21984609
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome.
Sullivan KE
Immunol Rev; 2019 Jan; 287(1):186-201. PubMed ID: 30565249
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
Sullivan KE; McDonald-McGinn D; Driscoll DA; Emanuel BS; Zackai EH; Jawad AF
Clin Diagn Lab Immunol; 1999 Nov; 6(6):906-11. PubMed ID: 10548584
[TBL] [Abstract][Full Text] [Related]
10. Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome.
McLean-Tooke A; Spickett GP; Gennery AR
Scand J Immunol; 2007 Jul; 66(1):1-7. PubMed ID: 17587340
[TBL] [Abstract][Full Text] [Related]
11. Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).
Kuo CY; Signer R; Saitta SC
Curr Allergy Asthma Rep; 2018 Oct; 18(12):75. PubMed ID: 30377837
[TBL] [Abstract][Full Text] [Related]
12. Accelerated Maturation, Exhaustion, and Senescence of T cells in 22q11.2 Deletion Syndrome.
Smetanova J; Milota T; Rataj M; Bloomfield M; Sediva A; Klocperk A
J Clin Immunol; 2022 Feb; 42(2):274-285. PubMed ID: 34716533
[TBL] [Abstract][Full Text] [Related]
13. Cat eye syndrome chromosome breakpoint clustering: identification of two intervals also associated with 22q11 deletion syndrome breakpoints.
McTaggart KE; Budarf ML; Driscoll DA; Emanuel BS; Ferreira P; McDermid HE
Cytogenet Cell Genet; 1998; 81(3-4):222-8. PubMed ID: 9730608
[TBL] [Abstract][Full Text] [Related]
14. Molecular Insights Into the Causes of Human Thymic Hypoplasia With Animal Models.
Bhalla P; Wysocki CA; van Oers NSC
Front Immunol; 2020; 11():830. PubMed ID: 32431714
[TBL] [Abstract][Full Text] [Related]
15. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
Jawad AF; McDonald-Mcginn DM; Zackai E; Sullivan KE
J Pediatr; 2001 Nov; 139(5):715-23. PubMed ID: 11713452
[TBL] [Abstract][Full Text] [Related]
16. Localization of 27 DNA markers to the region of human chromosome 22q11-pter deleted in patients with the DiGeorge syndrome and duplicated in the der22 syndrome.
Carey AH; Roach S; Williamson R; Dumanski JP; Nordenskjold M; Collins VP; Rouleau G; Blin N; Jalbert P; Scambler PJ
Genomics; 1990 Jul; 7(3):299-306. PubMed ID: 2365351
[TBL] [Abstract][Full Text] [Related]
17. Graves' disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion.
Brown JJ; Datta V; Browning MJ; Swift PG
J Pediatr Endocrinol Metab; 2004 Nov; 17(11):1575-9. PubMed ID: 15570997
[TBL] [Abstract][Full Text] [Related]
18. Interstitial deletion of chromosome 22 in a patient with the DiGeorge malformation sequence.
Mascarello JT; Bastian JF; Jones MC
Am J Med Genet; 1989 Jan; 32(1):112-4. PubMed ID: 2705472
[TBL] [Abstract][Full Text] [Related]
19. DiGeorge syndrome/chromosome 22q11.2 deletion syndrome.
Sullivan KE
Curr Allergy Asthma Rep; 2001 Sep; 1(5):438-44. PubMed ID: 11892070
[TBL] [Abstract][Full Text] [Related]
20. The diverse clinical features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome).
Maggadottir SM; Sullivan KE
J Allergy Clin Immunol Pract; 2013; 1(6):589-94. PubMed ID: 24565705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
